Cardano vs Enzyme — how do they compare? Cardano trades at Rp3,243 (market cap Rp118,34T, Rp3,58T 24h volume), while Enzyme trades at Rp30,212 (market cap Rp134,13M, Rp104,56M 24h volume). The key difference: Cardano is far larger — about 882278.4× Enzyme's market cap, and Cardano's supply is capped (36,6B / 45B ADA (82%)) while Enzyme's keeps growing. Which is the better fit depends on your goals — on Pluang, investors hold Cardano for 124 Days and Enzyme for 29 Days on average.
| ADA | MLN | |
|---|---|---|
Market Cap | Rp118,34T | Rp134,13M |
Volume (24h) | Rp3,58T | Rp104,56M |
Circulating Supply | 36,6B / 45B ADA (82%) | 3,3M MLN |
Typical Hold Time | 124 Days | 29 Days |
Signals from Pluang's Aura AI — not financial advice
Cardano (ADA) is currently trading at Rp3,243 with a bearish technical signal, showing mixed momentum indicators. The asset maintains 82% circulation with 36.6M ADA in supply. Key support levels sit at Rp3,082-3,213 while resistance zones range from Rp3,344-3,475. No major protocol updates or ecosystem developments were reported recently.
Overall outlook remains cautious with neutral oscillators suggesting consolidation. Opportunities exist near support levels, but risks include bearish moving averages and high volatility. Investors should monitor network activity and regulatory developments closely given the current technical weakness.
Enzyme (MLN) shows limited market activity with a market cap of Rp134,13M and circulating supply of 3,3jt tokens. The asset demonstrates a relatively short hold time of 29 days, suggesting active trading patterns. Current technical positioning requires updated price data for comprehensive analysis. Recent ecosystem developments appear limited based on available information.
Overall outlook remains cautious due to limited market data and ecosystem activity. Key opportunities include potential protocol upgrades and increased adoption, while major risks involve low liquidity and market volatility. Investors should monitor on-chain metrics and exchange listings for improved visibility.
What Pluang investors did over the last 30 days
No sentiment data available yet.
Latest headlines on both assets
A crypto asset known for its proof-of-stake (POS) blockchain. It was first developed by the co-founder of Ethereum in 2015 and launched in 2017. It is also used for the application of smart contracts. This crypto asset is also believed to be the better version of Ethereum.
Read more on ADA →Enzyme is an easy-to-use on-chain asset management system that enables access to digital assets and DeFi from one simple, unified app. It provides a front-to-back execution and order management system, which provides fully automated reporting, risk management, administration, governance and operations.
Read more on MLN →